Initiation and regulation of tissue factor-dependent blood coagulation.
1992; Volume: 12; Issue: 10 Linguagem: Inglês
10.1161/01.atv.12.10.1111
ISSN2330-9199
AutoresSamuel I. Rapaport, L. Vijaya Mohan Rao,
Tópico(s)Platelet Disorders and Treatments
ResumoHomeArteriosclerosis and Thrombosis: A Journal of Vascular BiologyVol. 12, No. 10Initiation and regulation of tissue factor-dependent blood coagulation. Free AccessAbstractAboutSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractInitiation and regulation of tissue factor-dependent blood coagulation. S I Rapaport and L V Rao S I RapaportS I Rapaport Department of Medicine, UCSD School of Medicine, La Jolla 92103. and L V RaoL V Rao Department of Medicine, UCSD School of Medicine, La Jolla 92103. Originally published1 Oct 1992https://doi.org/10.1161/01.ATV.12.10.1111Arteriosclerosis and Thrombosis: A Journal of Vascular Biology. 1992;12:1111–1121"Initiation and regulation of tissue factor-dependent blood coagulation.." Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 12(10), pp. 1111–1121 Previous Back to top Next FiguresReferencesRelatedDetailsCited By Gando S and Wada T (2021) Disseminated Intravascular Coagulation Trauma Induced Coagulopathy, 10.1007/978-3-030-53606-0_14, (217-242), . Garabet L, Ghanima W, Hellum M, Sandset P, Bussel J, Tran H and Henriksson C (2019) Increased microvesicle-associated thrombin generation in patients with immune thrombocytopenia after initiation of thrombopoietin receptor agonists, Platelets, 10.1080/09537104.2019.1639655, 31:3, (322-328), Online publication date: 2-Apr-2020. Arlati S (2019) Pathophysiology of Acute Illness and Injury Operative Techniques and Recent Advances in Acute Care and Emergency Surgery, 10.1007/978-3-319-95114-0_2, (11-42), . Gbyli R, Mercaldi A, Sundaram H and Amoako K (2017) Achieving Totally Local Anticoagulation on Blood Contacting Devices, Advanced Materials Interfaces, 10.1002/admi.201700954, 5:4, (1700954), Online publication date: 1-Feb-2018. Amoako K and Gbyli R (2018) Improving the hemocompatibility of biomedical polymers Hemocompatibility of Biomaterials for Clinical Applications, 10.1016/B978-0-08-100497-5.00016-1, (223-252), . Hedner U (2017) Mechanism of Action and Dosage Treating Life-Threatening Bleedings, 10.1016/B978-0-12-812439-0.00009-5, (129-141), . Cirillo P, Conte S, Cimmino G, Pellegrino G, Ziviello F, Barra G, Sasso F, Borgia F, De Palma R and Trimarco B (2017) Nobiletin inhibits oxidized-LDL mediated expression of Tissue Factor in human endothelial cells through inhibition of NF-κB, Biochemical Pharmacology, 10.1016/j.bcp.2016.12.016, 128, (26-33), Online publication date: 1-Mar-2017. Tunali-Akbay T, Solmaz Z, Pekiner F and İpekci H (2017) Salivary tissue factor concentration and activity in patients with oral lichen planus, Oral Science International, 10.1016/S1348-8643(16)30017-9, 14:1, (13-17), Online publication date: 1-Jan-2017. Hellum M, Trøseid A, Berg J, Brandtzaeg P, Øvstebø R and Henriksson C (2016) The Neisseria meningitidis lpxL1 mutant induces less tissue factor expression and activity in primary human monocytes and monocyte-derived microvesicles than the wild type meningococcus , Innate Immunity, 10.1177/1753425916684201, 23:2, (196-205), Online publication date: 1-Feb-2017. Gando S (2016) Disseminated Intravascular Coagulation Trauma Induced Coagulopathy, 10.1007/978-3-319-28308-1_13, (195-217), . Arderiu G, Peña E and Badimon L (2014) Angiogenic Microvascular Endothelial Cells Release Microparticles Rich in Tissue Factor That Promotes Postischemic Collateral Vessel Formation, Arteriosclerosis, Thrombosis, and Vascular Biology, 35:2, (348-357), Online publication date: 1-Feb-2015. Gando S and Otomo Y (2015) Local hemostasis, immunothrombosis, and systemic disseminated intravascular coagulation in trauma and traumatic shock, Critical Care, 10.1186/s13054-015-0735-x, 19:1, Online publication date: 1-Dec-2015. Hansen C, Ritschel V, Halvorsen S, Andersen G, Bjørnerheim R, Eritsland J, Arnesen H and Seljeflot I (2015) Markers of thrombin generation are associated with myocardial necrosis and left ventricular impairment in patients with ST-elevation myocardial infarction, Thrombosis Journal, 10.1186/s12959-015-0061-1, 13:1, Online publication date: 1-Dec-2015. Hellum M, Øvstebø R, Brusletto B, Berg J, Brandtzaeg P and Henriksson C (2014) Microparticle-associated tissue factor activity correlates with plasma levels of bacterial lipopolysaccharides in meningococcal septic shock, Thrombosis Research, 10.1016/j.thromres.2013.12.031, 133:3, (507-514), Online publication date: 1-Mar-2014. Saba H and Saba S (2014) Vascular Endothelium, Influence on Hemostasis: Past and Present Hemostasis and Thrombosis, 10.1002/9781118833391.ch2, (14-29) Bratseth V, Pettersen A, Opstad T, Arnesen H and Seljeflot I (2012) Markers of hypercoagulability in CAD patients. Effects of single aspirin and clopidogrel treatment, Thrombosis Journal, 10.1186/1477-9560-10-12, 10:1, (12), . Phinikaridou A, Qiao Y and Hamilton J (2011) Stable and Vulnerable Atherosclerotic Plaques Ultrasound and Carotid Bifurcation Atherosclerosis, 10.1007/978-1-84882-688-5_1, (3-25), . Becker R, Mahaffey K, Yang H, Marian A, Furman M, Michael Lincoff A, Hazen S, Petersen J, Reist C and Kleiman N (2010) Heparin-associated anti-Xa activity and platelet-derived prothrombotic and proinflammatory biomarkers in moderate to high-risk patients with acute coronary syndrome, Journal of Thrombosis and Thrombolysis, 10.1007/s11239-010-0532-y, 31:2, (146-153), Online publication date: 1-Feb-2011. Henriksson C, Hellum M, Haug K, Aass H, Joø G, Øvstebø R, Trøseid A, Klingenberg O and Kierulf P (2011) Anticoagulant effects of an antidiabetic drug on monocytes in vitro, Thrombosis Research, 10.1016/j.thromres.2011.07.007, 128:5, (e100-e106), Online publication date: 1-Nov-2011. Amoako K and Cook K (2011) Nitric Oxide-Generating Silicone As a Blood-Contacting Biomaterial, ASAIO Journal, 10.1097/MAT.0b013e31823b9692, 57:6, (539-544), Online publication date: 1-Nov-2011. RODRIGUEZ-MERCHAN E, JIMENEZ-YUSTE V, AZNAR J, HEDNER U, KNOBE K, LEE C, LJUNG R, QUEROL F, SANTAGOSTINO E, VALENTINO L and CAFFARINI A (2011) Joint protection in haemophilia, Haemophilia, 10.1111/j.1365-2516.2011.02615.x, 17, (1-23), Online publication date: 1-Sep-2011. Dusse L, Carvalho M, Cooper A and Lwaleed B (2011) Plasma factor VII: A potential marker of pre-eclampsia, Thrombosis Research, 10.1016/j.thromres.2010.10.022, 127:1, (e15-e19), Online publication date: 1-Jan-2011. SEN P, KOMISSAROV A, FLOROVA G, IDELL S, PENDURTHI U and VIJAYA MOHAN RAO L (2011) Plasminogen activator inhibitor-1 inhibits factor VIIa bound to tissue factor, Journal of Thrombosis and Haemostasis, 10.1111/j.1538-7836.2010.04167.x, 9:3, (531-539), Online publication date: 1-Mar-2011. Basavaraj M, Gruber F, Sovershaev M, Appelbom H, Østerud B, Petersen L and Hansen J (2010) The role of TFPI in regulation of TF-induced thrombogenicity on the surface of human monocytes, Thrombosis Research, 10.1016/j.thromres.2010.07.014, 126:5, (418-425), Online publication date: 1-Nov-2010. Freestone B, Krishnamoorthy S and Lip G (2014) Assessment of endothelial dysfunction, Expert Review of Cardiovascular Therapy, 10.1586/erc.09.184, 8:4, (557-571), Online publication date: 1-Apr-2010. Zhou J, Wang Y, Xiong Y, Wang H, Feng Y and Chen J (2010) Delivery of TFPI-2 Using Ultrasound with a Microbubble Agent (SonoVue) Inhibits Intimal Hyperplasia after Balloon Injury in a Rabbit Carotid Artery Model, Ultrasound in Medicine & Biology, 10.1016/j.ultrasmedbio.2010.08.013, 36:11, (1876-1883), Online publication date: 1-Nov-2010. Mishra J, Samanta K, Jain M, Dikshit M and Panda G (2010) Amino acid based enantiomerically pure 3-substituted benzofused heterocycles: A new class of antithrombotic agents, Bioorganic & Medicinal Chemistry Letters, 10.1016/j.bmcl.2009.10.126, 20:1, (244-247), Online publication date: 1-Jan-2010. Karatela R and Sainani G (2009) Interrelationship between coagulation factor VII and obesity in diabetes mellitus (type 2), Diabetes Research and Clinical Practice, 10.1016/j.diabres.2009.02.018, 84:3, (e41-e44), Online publication date: 1-Jun-2009. Oen E, Doan K, Knoderer C and Knoderer H (2009) Recombinant Factor VIIa for Bleeding in Non-hemophiliac Pediatric Patients, The Journal of Pediatric Pharmacology and Therapeutics, 10.5863/1551-6776-14.1.38, 14:1, (38-47), Online publication date: 1-Jan-2009. Hedner U and Ezban M (2008) Recent advances in clot biology and assessment of clotting, Trauma, 10.1177/1460408608098295, 10:4, (261-270), Online publication date: 1-Oct-2008. RODRIGUEZ-MERCHAN E, HEDNER U, HEIJNEN L, JIMENEZ-YUSTE V, LEE C, MORFINI M, QUEROL F, ROOSENDAAL G, SANTAGOSTINO E and SOLIMENO L (2008) Prevention of haemophilic arthropathy during childhood. May common orthopaedic management be extrapolated from patients without inhibitors to patients with inhibitors?, Haemophilia, 10.1111/j.1365-2516.2008.01892.x, 14, (68-81), Online publication date: 1-Nov-2008. Badimon L, Fernández-Ortiz A and Vilahur G (2008) Fundamentals of the thrombosis cascade Clinical Guide to the Use of Antithrombotic Drugs in Coronary Artery Disease, 10.3109/9780203091494-3, (3-10), Online publication date: 8-Apr-2008. Zhang Z and Yin X (2008) Impact of Adenovirus-mediated Local Expression of Human Tissue Factor Pathway Inhibitor on Vascular Smooth Muscular Cell Proliferation and Apoptosis in the Stent-implanted Femoral Artery of the Rabbit, Journal of International Medical Research, 10.1177/147323000803600323, 36:3, (567-571), Online publication date: 1-May-2008. Mälarstig A and Siegbahn A (2007) The intersubject variability of tissue factor mRNA production in human monocytes—relation with the toll-like receptor 4, Thrombosis Research, 10.1016/j.thromres.2006.10.008, 120:3, (407-413), Online publication date: 1-Jan-2007. Hedner U (2007) Recombinant factor VIIa: its background, development and clinical use, Current Opinion in Hematology, 10.1097/MOH.0b013e3280dce57b, 14:3, (225-229), Online publication date: 1-May-2007. Hedner U and Brun N (2007) Recombinant factor VIIa (rFVIIa): its potential role as a hemostatic agent, Neuroradiology, 10.1007/s00234-007-0240-2, 49:10, (789-793), Online publication date: 25-Sep-2007. El Solh A, Choi G, Schultz M, Pineda L and Mankowski C (2007) Clinical and hemostatic responses to treatment in ventilator-associated pneumonia: Role of bacterial pathogens*, Critical Care Medicine, 10.1097/01.CCM.0000253308.93761.09, 35:2, (490-496), Online publication date: 1-Feb-2007. Müller A, Maas M, Kozianka U and Franke F (2006) Expression des Angiotensin converting enzyme (ACE) bei pulmonaler HypertonieExpression of angiotensin I converting enzyme in pulmonary hypertension, Der Pathologe, 10.1007/s00292-006-0820-7, 27:2, (133-139), Online publication date: 1-Mar-2006. HEDNER U (2006) Potential role of recombinant factor FVIIa in prophylaxis in severe hemophilia patients with inhibitors, Journal of Thrombosis and Haemostasis, 10.1111/j.1538-7836.2006.02166.x, 4:11, (2498-2500), Online publication date: 1-Nov-2006. Mayr F and Jilma B (2006) Coagulation interventions in experimental human endotoxemia, Translational Research, 10.1016/j.trsl.2006.08.002, 148:5, (263-271), Online publication date: 1-Nov-2006. Grizelj R, Vuković J, Filipović-Grčić B, Šarić D and Luetić T (2006) Successful use of recombinant activated FVII and aminocaproic acid in four neonates with life-threatening hemorrhage, Blood Coagulation & Fibrinolysis, 10.1097/01.mbc.0000233373.71970.6f, 17:5, (413-415), Online publication date: 1-Jul-2006. Yusim Y, Perel A, Berkenstadt H, Attia M, Knoller N and Sidi A (2006) The use of recombinant factor VIIa (NovoSeven) for treatment of active or impending bleeding in brain injury: broadening the indications, Journal of Clinical Anesthesia, 10.1016/j.jclinane.2006.02.012, 18:7, (545-551), Online publication date: 1-Nov-2006. Hedner U (2006) Mechanism of Action of Recombinant Activated Factor VII: An Update, Seminars in Hematology, 10.1053/j.seminhematol.2005.11.025, 43, (S105-S107), Online publication date: 1-Jan-2006. Hedner U (2006) Mechanism of action, development and clinical experience of recombinant FVIIa, Journal of Biotechnology, 10.1016/j.jbiotec.2006.03.042, 124:4, (747-757), Online publication date: 1-Aug-2006. Morel N, Morel O, Delabranche X, Jesel L, Sztark F, Dabadie P, Freyssinet J and Toti F (2006) Microparticules circulantes au cours des traumatismes graves et des sepsis : un élément du couplage inflammation–thrombose, Annales Françaises d'Anesthésie et de Réanimation, 10.1016/j.annfar.2006.04.013, 25:9, (955-966), Online publication date: 1-Sep-2006. Ravassa S, Bennaghmouch A, Kenis H, Lindhout T, Hackeng T, Narula J, Hofstra L and Reutelingsperger C (2005) Annexin A5 Down-regulates Surface Expression of Tissue Factor, Journal of Biological Chemistry, 10.1074/jbc.M411710200, 280:7, (6028-6035), Online publication date: 1-Feb-2005. Wiel E, Vallet B and ten Cate H (2005) The Endothelium in Intensive Care, Critical Care Clinics, 10.1016/j.ccc.2005.03.001, 21:3, (403-416), Online publication date: 1-Jul-2005. Ogawa T, Verhamme I, Sun M, Bock P and Gailani D (2005) Exosite-mediated Substrate Recognition of Factor IX by Factor XIa, Journal of Biological Chemistry, 10.1074/jbc.M500894200, 280:25, (23523-23530), Online publication date: 1-Jun-2005. Rose S and Babensee J (2005) Procoagulant phenotype of endothelial cells after coculture with biomaterial-treated blood cells, Journal of Biomedical Materials Research Part A, 10.1002/jbm.a.30222, 72A:3, (269-278), Online publication date: 1-Mar-2005. Monaco C, Mathur A and Martin J (2005) What causes acute coronary syndromes? Applying Koch's postulates, Atherosclerosis, 10.1016/j.atherosclerosis.2004.10.022, 179:1, (1-15), Online publication date: 1-Mar-2005. Jayachandran M, Sanzo A, Owen W and Miller V (2005) Estrogenic regulation of tissue factor and tissue factor pathway inhibitor in platelets, American Journal of Physiology-Heart and Circulatory Physiology, 10.1152/ajpheart.01292.2004, 289:5, (H1908-H1916), Online publication date: 1-Nov-2005. Wittenstein B, Ng C, Ravn H and Goldman A (2005) Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery, Pediatric Critical Care Medicine, 10.1097/01.PCC.0000162449.55887.B9, 6:4, (473-476), Online publication date: 1-Jul-2005. Toh C (2005) 2 Between bleeding and thrombosis or beyond Multidisciplinary Approaches to Theory in Medicine, 10.1016/S1571-0831(06)80006-7, (15-30), . Bolt G, Kristensen C and Steenstrup T (2004) Posttranslational N-glycosylation takes place during the normal processing of human coagulation factor VII, Glycobiology, 10.1093/glycob/cwi032, 15:5, (541-547), Online publication date: 1-May-2005. MADAMANCHI N, HAKIM Z and RUNGE M (2005) Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes, Journal of Thrombosis and Haemostasis, 10.1111/j.1538-7836.2004.01085.x, 3:2, (254-267), Online publication date: 1-Feb-2005. Price G, Thompson S and Kam P (2004) Tissue factor and tissue factor pathway inhibitor, Anaesthesia, 10.1111/j.1365-2044.2004.03679.x, 59:5, (483-492), Online publication date: 1-May-2004. Abshire T and Kenet G (2004) Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors, Journal of Thrombosis and Haemostasis, 10.1111/j.1538-7836.2004.00759.x, 2:6, (899-909), Online publication date: 1-Jun-2004. Ravindranath T, Goto M, Demir M, Tobu M, Kujawski M, Hoppensteadt D, Samonte V, Iqbal O, Sayeed M and Fareed J (2016) Tissue Factor Pathway Inhibitor and Thrombin Activatable Fibrinolytic Inhibitor Plasma Levels following Burnand Septic Injuries in Rats, Clinical and Applied Thrombosis/Hemostasis, 10.1177/107602960401000411, 10:4, (379-385), Online publication date: 1-Oct-2004. Dietzen D, Page K and Tetzloff T (2004) Lipid rafts are necessary for tonic inhibition of cellular tissue factor procoagulant activity, Blood, 10.1182/blood-2003-07-2399, 103:8, (3038-3044), Online publication date: 15-Apr-2004. Gorbet M and Sefton M (2004) Review: Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes The Biomaterials: Silver Jubilee Compendium, 10.1016/B978-008045154-1.50025-3, (219-241), . Brey R (2004) New treatment option for the antiphospholipid antibody syndrome? More pleiotropic effects of the statin drugs, Journal of Thrombosis and Haemostasis, 10.1111/j.1538-7836.2004.00904.x, 2:9, (1556-1557) Brey R (2004) Management of the neurological manifestations of APS—what do the trials tell us?, Thrombosis Research, 10.1016/j.thromres.2004.06.018, 114:5-6, (489-499), Online publication date: 1-Jan-2004. Gorbet M and Sefton M (2004) Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes, Biomaterials, 10.1016/j.biomaterials.2004.01.023, 25:26, (5681-5703), Online publication date: 1-Nov-2004. Métais C, Wiel E and Vallet B (2004) Rôle de la dysfonction endothéliale dans la mortalité liée au sepsis, Therapies, 10.2515/therapie:2004007, 59:1, (31-40), Online publication date: 1-Jan-2004. Dutton R, McCunn M, Hyder M, D'Angelo M, O'Connor J, Hess J and Scalea T (2004) Factor VIIa for Correction of Traumatic Coagulopathy, The Journal of Trauma: Injury, Infection, and Critical Care, 10.1097/01.TA.0000140646.66852.AB, 57:4, (709-719), Online publication date: 1-Oct-2004. Silva M, Muralidharan V and Mirza D (2004) The management of coagulopathy and blood loss in liver surgery, Seminars in Hematology, 10.1053/j.seminhematol.2003.11.022, 41, (132-139), Online publication date: 1-Jan-2004. Willardsen J, Dudley D, Cody W, Chi L, McClanahan T, Mertz T, Potoczak R, Narasimhan L, Holland D, Rapundalo S and Edmunds J (2004) Design, Synthesis, and Biological Activity of Potent and Selective Inhibitors of Blood Coagulation Factor Xa, Journal of Medicinal Chemistry, 10.1021/jm0497491, 47:16, (4089-4099), Online publication date: 1-Jul-2004. D'Andrea D, Ravera M, Golino P, Rosica A, De Felice M, Ragni M, Cirillo P, Vigorito F, Corcione N, Tommasini P, Gargiulo A, Piro O, Calabró P and Chiariello M (2003) Induction of Tissue Factor in the Arterial Wall During Recurrent Thrombus Formation, Arteriosclerosis, Thrombosis, and Vascular Biology, 23:9, (1684-1689), Online publication date: 1-Sep-2003. Morenski J, Tobias J and Jimenez D Recombinant activated factor VII for cerebral injury—induced coagulopathy in pediatric patients, Journal of Neurosurgery, 10.3171/jns.2003.98.3.0611, 98:3, (611-616) Quintana Díaz M, Cabestrero Alonso D, Mateos and García De Lorenzo A (2003) Coagulación y hemorragia en el paciente crítico: patrón, pruebas diagnósticas y etiología, Medicina Intensiva, 10.1016/S0210-5691(03)79973-2, 27:9, (605-614), Online publication date: 1-Jan-2003. Cirillo P, Golino P, Calabrò P, Ragni M, Forte L, Piro O, De Rosa S, Pacileo M and Chiariello M (2003) Activated platelets stimulate tissue factor expression in smooth muscle cells, Thrombosis Research, 10.1016/j.thromres.2003.11.011, 112:1-2, (51-57), Online publication date: 1-Jan-2003. Aktimur A, Gabriel M, Gailani D and Toomey J (2003) The Factor IX γ-Carboxyglutamic Acid (Gla) Domain Is Involved in Interactions between Factor IX and Factor XIa, Journal of Biological Chemistry, 10.1074/jbc.M212748200, 278:10, (7981-7987), Online publication date: 1-Mar-2003. Esmon C (2003) Inflammation and thrombosis, Journal of Thrombosis and Haemostasis, 10.1046/j.1538-7836.2003.00261.x, 1:7, (1343-1348), Online publication date: 1-Jul-2003. Moons A, Peters R, Bijsterveld N, Piek J, Prins M, Vlasuk G, Rote W and Büller H (2003) Recombinant nematode anticoagulant protein c2, an inhibitor of the tissue factor/factor VIIa complex, in patients undergoing elective coronary angioplastyAppendix, Journal of the American College of Cardiology, 10.1016/S0735-1097(03)00478-9, 41:12, (2147-2153), Online publication date: 1-Jun-2003. Gando S, Kameue T, Matsuda N, Hayakawa M, Morimoto Y, Ishitani T and Kemmotsu O (2003) Imbalances between the levels of tissue factor and tissue factor pathway inhibitor in ARDS patients, Thrombosis Research, 10.1016/S0049-3848(03)00151-8, 109:2-3, (119-124), Online publication date: 1-Jan-2003. von Känel R, Dimsdale J, Adler K, Dillon E, Perez C and Mills P (2003) Effects of nonspecific β-adrenergic stimulation and blockade on blood coagulation in hypertension, Journal of Applied Physiology, 10.1152/japplphysiol.00892.2002, 94:4, (1455-1459), Online publication date: 1-Apr-2003. Cirillo P, Golino P, Ragni M, D'andrea D, Calabro P, Corcione N, Vigorito F, Ravera M and Chiariello M (2003) Long-lasting antithrombotic effects of a single dose of human recombinant, active site-blocked factor VII: insights into possible mechanism(s) of action, Journal of Thrombosis and Haemostasis, 10.1046/j.1538-7836.2003.00235.x, 1:5, (992-998), Online publication date: 1-May-2003. Dutton R, Hess J and Scalea T (2003) Recombinant factor viia for control of hemorrhage: early experience in critically ill trauma patients, Journal of Clinical Anesthesia, 10.1016/S0952-8180(03)00034-5, 15:3, (184-188), Online publication date: 1-May-2003. Vallet B, Wiel E and Rodie-Talbère P (2002) Endothelial Cell Dysfunction and Abnormal Tissue Perfusion Mechanisms of Organ Dysfunction in Critical Illness, 10.1007/978-3-642-56107-8_12, (175-190), . Kubo-Inoue M, Egashira K, Usui M, Takemoto M, Ohtani K, Katoh M, Shimokawa H and Takeshita A (2002) Long-term inhibition of nitric oxide synthesis increases arterial thrombogenecity in rat carotid artery, American Journal of Physiology-Heart and Circulatory Physiology, 10.1152/ajpheart.00739.2001, 282:4, (H1478-H1484), Online publication date: 1-Apr-2002. Peek M, Moran P, Mendoza N, Wickramasinghe D and Kirchhofer D (2002) Unusual Proteolytic Activation of Pro-hepatocyte Growth Factor by Plasma Kallikrein and Coagulation Factor XIa, Journal of Biological Chemistry, 10.1074/jbc.M209778200, 277:49, (47804-47809), Online publication date: 1-Dec-2002. Salvemini D and Cuzzocrea S (2002) Oxidative stress in septic shock and disseminated intravascular coagulation, Free Radical Biology and Medicine, 10.1016/S0891-5849(02)00961-9, 33:9, (1173-1185), Online publication date: 1-Nov-2002. Hedner U and Erhardtsen E (2002) Potential role for rFVIIa in transfusion medicine, Transfusion, 10.1046/j.1537-2995.2002.00017.x, 42:1, (114-124), Online publication date: 1-Jan-2002. Kunzelmann C, Toti F, Freyssinet J and Meyer D (2002) Interference of activated factor VII in apoptotis of erytholeukemic K562 cells, Comptes Rendus Biologies, 10.1016/S1631-0691(02)01522-6, 325:11, (1111-1118), Online publication date: 1-Nov-2002. Gando S, Kameue T, Morimoto Y, Matsuda N, Hayakawa M and Kemmotsu O (2002) Tissue factor production not balanced by tissue factor pathway inhibitor in sepsis promotes poor prognosis*, Critical Care Medicine, 10.1097/00003246-200208000-00009, 30:8, (1729-1734), Online publication date: 1-Aug-2002. Plutzky J (2002) PPARα and Atherosclerosis Peroxisome Proliferator Activated Receptors: From Basic Science to Clinical Applications, 10.1007/978-1-4615-1171-7_11, (81-87), . Molitoris B, Sandoval R and Sutton T (2002) Endothelial injury and dysfunction in ischemic acute renal failure, Critical Care Medicine, 10.1097/00003246-200205001-00011, 30:Supplement, (S235-S240), Online publication date: 1-May-2002. Sutton T, Fisher C and Molitoris B (2002) Microvascular endothelial injury and dysfunction during ischemic acute renal failure, Kidney International, 10.1046/j.1523-1755.2002.00631.x, 62:5, (1539-1549), Online publication date: 1-Nov-2002. Lynn M, Jerokhimov I, Jewelewicz D, Popkin C, Johnson E, Rashid Q, Brown M, Martinowitz U and Cohn S (2002) Early Use of Recombinant Factor VIIa Improves Mean Arterial Pressure and May Potentially Decrease Mortality in Experimental Hemorrhagic Shock: A Pilot Study, The Journal of Trauma: Injury, Infection, and Critical Care, 10.1097/00005373-200204000-00016, 52:4, (703-707), Online publication date: 1-Apr-2002. Yang R, Ng C, Wasserman S, Colman S, Shenoy S, Mehraban F, Kömüves L, Tomlinson J and Topper J (2002) Identification of a Novel Family of Cell-surface Proteins Expressed in Human Vascular Endothelium, Journal of Biological Chemistry, 10.1074/jbc.M207410200, 277:48, (46364-46373), Online publication date: 1-Nov-2002. Dhainaut J and Vallet B (2001) Combined procoagulant and innate immune responses to infection: Toward more potent drugs in septic patients, Critical Care Medicine, 10.1097/00003246-200101000-00043, 29:1, (205-207), Online publication date: 1-Jan-2001. Hedner U (2001) Use of High Dose Factor Vila in Hemophilia Patients Hemophilia Care in the New Millennium, 10.1007/978-1-4615-1277-6_7, (75-88), . Hansen C, Pyke C, Petersen L and Rao L (2001) Tissue factor–mediated endocytosis, recycling, and degradation of factor VIIa by a clathrin-independent mechanism not requiring the cytoplasmic domain of tissue factor, Blood, 10.1182/blood.V97.6.1712, 97:6, (1712-1720), Online publication date: 15-Mar-2001. Masuoka H, Ito M, Kamei S, Ozaki M, Kawasaki A and Nakano T (2001) Level of Plasma Tissue Factor Pathway Inhibitor is Inversely Correlated With Intraarterial Diastolic Pressure in Subjects Who Underwent Coronary Angiography, Japanese Circulation Journal, 10.1253/jcj.65.165, 65:3, (165-170), . Bergum P, Cruikshank A, Maki S, Kelly C, Ruf W and Vlasuk G (2001) Role of Zymogen and Activated Factor X as Scaffolds for the Inhibition of the Blood Coagulation Factor VIIa-Tissue Factor Complex by Recombinant Nematode Anticoagulant Protein c2, Journal of Biological Chemistry, 10.1074/jbc.M009116200, 276:13, (10063-10071), Online publication date: 1-Mar-2001. Kario K, Barton Duell P, Matsuo T, Sakata T, Kato H, Shimada K and Miyata T (2001) High plasma homocyst(e)ine levels in elderly Japanese patients are associated with increased cardiovascular disease risk independently from markers of coagulation activation and endothelial cell damage, Atherosclerosis, 10.1016/S0021-9150(00)00738-3, 157:2, (441-449), Online publication date: 1-Aug-2001. Zoldhelyi P, Chen Z, Shelat H, McNatt J and Willerson J (2001) Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries, Proceedings of the National Academy of Sciences, 10.1073/pnas.061004098, 98:7, (4078-4083), Online publication date: 27-Mar-2001. Erhardtsen E, Nilsson P, Johannessen M and Thomsen M (2013) Pharmacokinetics and Safety of FFR-rFVIIa after Single Doses in Healthy Subjects, The Journal of Clinical Pharmacology, 10.1177/00912700122010780, 41:8, (880-885), Online publication date: 1-Aug-2001. Martinowitz U, Holcomb J, Pusateri A, Stein M, Onaca N, Freidman M, Macaitis J, Castel D, Hedner U and Hess J (2001) Intravenous rFVIIa Administered for Hemorrhage Control in Hypothermic Coagulopathic Swine with Grade V Liver Injuries, The Journal of Trauma: Injury, Infection, and Critical Care, 10.1097/00005373-200104000-00021, 50:4, (721-729), Online publication date: 1-Apr-2001. E. Ejlersen, T. Melsen, J. Ingersle (2009) Recombinant Activated Factor VII (rFVIIa) Acutely Normalizes Prothrombin Time in Patients with Cirrhosis During Bleeding from Oesophageal Varices, Scandinavian Journal of Gastroenterology, 10.1080/003655201750422701, 36:10, (1081-1085), Online publication date: 1-Jan-2001. Vallet B and Wiel E (2001) Endothelial cell dysfunction and coagulation, Critical Care Medicine, 10.1097/00003246-200107001-00015, 29, (S36-S41), Online publication date: 1-Jul-2001. Banai S and Gertz S (2001) Tissue factor as a therapeutic target in coronary syndromes, The American Journal of Cardiology, 10.1016/S0002-9149(00)01499-5, 87:6, (763-765), Online publication date: 1-Mar-2001. Gando S, Nanzaki S, Morimoto Y, Ishitani T and Kemmotsu O (2001) Tissue factor pathway inhibitor response does not correlate with tissue factor-induced disseminated intravascular coagulation and multiple organ dysfunction syndrome in trauma patients, Critical Care Medicine, 10.1097/00003246-200102000-00006, 29:2, (262-266), Online publication date: 1-Feb-2001. Gailani D, Ho D, Sun M, Cheng Q and Walsh P (2001) Model for a factor IX activation complex on blood platelets: dimeric conformation of factor XIa is essential, Blood, 10.1182/blood.V97.10.3117, 97:10, (3117-3122), Online publication date: 15-May-2001. Hedner U, Ginsburg D, Lusher J and High K (2000) Congenital Hemorrhagic Disorders: New Insights into the Pathophysiology and Treatment of Hemophilia, Hematology, 10.1182/asheducation.V2000.1.241.20000241, 2000:1, (241-265), Online publication date: 1-Jan-2000. Hedner U, Ginsburg D, Lusher J and High K (2000) Congenital Hemorrhagic Disorders: New Insights into the Pathophysiology and Treatment of Hemophilia, Hematology, 10.1182/asheducation.V2000.1.241.241, 2000:1, (241-265), Online publication date: 1-Jan-2000. Dudley D, Bunker A, Chi L, Cody W, Holland D, Ignasiak D, Janiczek-Dolphin N, McClanahan T, Mertz T, Narasimhan L, Rapundalo S, Trautschold J, Van Huis C and Edmunds J (2000) Rational Design, Synthesis, and Biological Activity of Benzoxazinones as Novel Factor Xa Inhibitors, Journal of Medicinal Chemistry, 10.1021/jm000074l, 43:22, (4063-4070), Online publication date: 1-Nov-2000. Golino P, Ragni M, Cirillo P, Scognamiglio A, Ravera A, Buono C, Guarino A, Piro O, Lambiase C, Botticella F, Ezban M, Condorelli M and Chiariello M (2000) Recombinant human, active site-blocked factor VIIa reduces infarct size and no-reflow phenomenon in rabbits, American Journal of Physiology-Heart and Circulatory Physiology, 10.1152/ajpheart.2000.278.5.H1507, 278:5, (H1507-H1516), Online publication date: 1-May-2000. Adams
Referência(s)